MEDICINAL CHEMISTRY a Series of Monographs a Complete List of Titles in This Series Appears at the End of This Volume

Total Page:16

File Type:pdf, Size:1020Kb

MEDICINAL CHEMISTRY a Series of Monographs a Complete List of Titles in This Series Appears at the End of This Volume MEDICINAL CHEMISTRY A Series of Monographs A complete list of titles in this series appears at the end of this volume. DOXORUBICIN Anticancer Antibiotics FEDERICO ARCAMONE Farmitalia Carlo Erba Ricerca e Sviluppo Chimico Milano, Italy 1981 ACADEMIC PRESS A Subsidiary of Har court Brace Jovanovich, Publishers New York London Toronto Sydney San Francisco COPYRIGHT © 1981, BY ACADEMIC PRESS, INC. ALL RIGHTS RESERVED. NO PART OF THIS PUBLICATION MAY BE REPRODUCED OR TRANSMITTED IN ANY FORM OR BY ANY MEANS, ELECTRONIC OR MECHANICAL, INCLUDING PHOTOCOPY, RECORDING, OR ANY INFORMATION STORAGE AND RETRIEVAL SYSTEM, WITHOUT PERMISSION IN WRITING FROM THE PUBLISHER. ACADEMIC PRESS, INC. Ill Fifth Avenue, New York, New York 10003 United Kingdom Edition published by ACADEMIC PRESS, INC. (LONDON) LTD. 24/28 Oval Road, London NW1 7DX Library of Congress Cataloging in Publication Data Arcamone, Federico. Doxorubicin. (Medicinal chemistry, a series of monographs) Includes bibliographies and index. 1. Adriamycin. 2. Cancer—Chemotheraphy. 3. Anti­ neoplastic agents. I. Title. II. Series. [DNLM: 1. Doxorubicin. 2. Doxorubicin—Analogs and derivatives. 3. Antibiotics, Antineoplastic. Wl ME64 / 0V 269 A668d] RC271.A37A72 616.99Ά061 80-1106 ISBN 0-12-059280-0 PRINTED IN THE UNITED STATES OF AMERICA 81 82 83 84 9 8 7 6 5 4 3 2 1 To my Wife and Children Preface The successful development of doxorubicin as a wide-spectrum antitumor an­ tibiotic was the result of a systematic search of the most effective chemical species within a group of biologically active microbial metabolites, namely the anthracycline glycosides. Starting from the classical rhodomycins, an inter­ mediate step was represented by the study of the first S. peucetius-den\ed metabolite, daunorubicin. Important determinants of this development (sum­ marized in Chapter 1) were (a) the involvement of organic chemistry at an early stage (in the elucidation of the detailed structure and stereochemistry of daunorubicin), which allowed the rapid identification of doxorubicin and ensured its prompt availability for the clinical trials; (b) the well-established, pioneering expertise in experimental chemotherapy of Professor Aurelio di Marco and his group at Istituto Nazionale Tumori, Milan, who demonstrated the high therapeu­ tic potential of the new drug; and (c) the highly motivated interest of experienced clinicians whose contributions are clearly visible in the early relevant medical literature in a frame of extensive international cooperation, most importantly, that provided by the United States National Cancer Institute, Division of Cancer Treatment, Bethesda, Maryland. Chemotherapy as a clinically useful approach to the treatment of human cancer, as an alternative or an addition to surgery and radiotherapy, is now nearly 40 years old; but only in the last decade have its objectives become those of cure or even of prolonged survival of a disease that strikes people at a rate of almost one in four and that represents the second leading cause of death in the United States (as estimated by the American Cancer Society in "Cancer Facts and Fig­ ures," 1978). The future of antitumor drug development rests in part on a more rational use of presently known, clinically effective agents and in part on the discovery and selection of new chemical compounds affording a reduction both of host toxicity and of variations in tumor responsiveness. The advantages as- XI xii Preface sociated with optimal drug dosage, scheduling, and combination are certainly important, but they lie outside the field of the medicinal chemist. However, the latter have already produced highly active compounds by synthesizing analogues of proven active leads (e.g., methotrexate, doxorubicin itself, CCNU, vincris- tine, cyclophosphamide). The analogues development approach in the field of anthracyclines is fully justified by the outstanding antitumor activity exhibited by doxorubicin and by the identification of its major side effects, whose dissociation from the therapeutic effects seems, at least in part, possible. Although adequate knowledge of the chemistry involved is a necessary prerequisite for performing appropriate structural variations of the parent drug, the consideration of biochem­ ical and pharmacological properties presumably associated with the clinical ef­ fects is of undoubted importance in assisting the medicinal chemist. Chapters 2 through 8 provide an overview of basic studies in the area of medi­ cinal chemistry and related fields that have been generated as a consequence of doxorubicin development. Such studies have been concerned, on the one hand, with both biochemical and biophysical investigations at the molecular level (the interaction of anthracyclines with DNA having attracted much attention since this cellular constituent appears to be the main receptor of these drugs) and at different levels of biological organization as well. On the other hand, a large body of work whose objective is the development of synthetic procedures for the drug and for new related analogs of potential clinical usefulness has been carried out. New biosynthetic anthracyclines have also been isolated as interest in this family of antibiotics has grown in recent years. This approach remains promising for the identification of new biologically active compounds. Acknowledgments The author wishes to acknowledge the very great assistance of Mrs. Domenica Ambroggio who typed most of the manuscript and whose cooperation in the collection of photocopies of many original articles and in checking and listing the literature references was indeed essential to the completion of this work. The author is also grateful to Mrs. Mara Chierichetti for collaboration in the prepara­ tion of the typescript. The author was assisted in the revision of the text by his colleagues and friends—Giovanni Franceschi, Giuseppe Cassinelli, Sergio Penco, Aristide Vigevani and Milena Menozzi—who read large parts of the manuscript. This assistance was particularly valuable since they had each been directly involved in many of the studies reported in this book. Xlll 1 Discovery and Development of Doxorubicin ANTITUMOR ACTIVITY OF AN ANTHRACYCLINE PIGMENT The history of the antitumor anthracyclines begins in the late 1950s when a pigmented compound originated from a strain of Streptomyces sp. was characterized and found to exhibit antitumor properties (7). The strain (number 1683 in Farmitalia collection) was isolated from a sample of soil collected in India and displayed a tendency to produce varieties differing phenotypically in the color and the amount of pigmentation. Solvent ex­ traction of both the mycelium and the filtered broth allowed the recovery of the active materials as orange-red or red solids containing one or more hydroxyquinone compounds as shown by the typical absorption spectrum in the ultraviolet and visible regions. The product was purified by the counter- current technique in a Craig's apparatus (chloroform and pH 4.6 acetate buffer) and eventually crystallized as the hydrochloride. It was considered to be closely related to the rhodomycin complex, previously described by Brockmann (2). Later work performed in the author's laboratory showed the main pigment produced by strain 1683 to be rhodomycin B, a component of the rhodomycin complex whose structure has been established as 1 by the German authors (3). Biological activity was studied in mice bearing Ehrlich carcinoma or sarcoma 180 both in solid and ascites form. The products were administered intraperitoneally for 5 consecutive days starting the day of ascitic tumor inoculation or subcutaneously in single daily doses for 9 or 10 days starting from day 1 after the transplant of the solid tumors. The crude solids obtain­ ed upon H-butanol extraction of fermentation fluids allowed a marked 1 1 Discovery and Development of Doxorubicin O OH OH NMe- HO (1) inhibition of the Ehrlich ascitic tumor when administered at the daily dose of 200 mg to the experimental animals. Survival time of treated animals was, however, not different from that of the controls. Purified pigmented preparations gave similar results at daily doses in the range 0.05-0.25 mg/kg. The latter materials in their water soluble form, i.e., as the intact glycosides, showed also a marked effect on sarcoma 180 in both ascitic and solid form and on Ehrlich adenocarcinoma. In all cases, no favorable effects on survival time were demonstrated, and this was attributed to toxicity of the active principle and especially to the paralyzing effect caused by the substances on intestinal motility. Biological properties of the pigmented substances isolated from strain 1683 indicated, however, that further investigations on new compounds belonging to this class of microbial metabolites would have been of interest. This early conclusion was also supported by the cytostatic and antitumor activity exhibited by the related pigments, the cinerubins (4). Before dealing with the isolation and structure elucidation of daunorubicin and doxorubicin which took place during the 1960s, a summary of work already done in the preceding decade on this class of glycoside pigments is obligatory. This will be the subject of the following section. ANTHRACYCLINES AND ANTHRACYCLINONES: THE FIRST DECADE Starting in 1950 with a publication in Naturwissenschaften by Hans Brock- mann and Klaus Bauer entitled "Rhodomycin, ein rotes Antibioticum aus Actinomyceten," Brockmann and co-workers at the University of Göttingen had already disclosed in a number of papers the
Recommended publications
  • Separation of Hydroxyanthraquinones by Chromatography
    Separation of hydroxyanthraquinones by chromatography B. RITTICH and M. ŠIMEK* Research Institute of Animal Nutrition, 691 23 Pohořelice Received 6 May 1975 Accepted for publication 25 August 1975 Chromatographic properties of hydroxyanthraquinones have been examined. Good separation was achieved using new solvent systems for paper and thin-layer chromatography on common and impregnated chromatographic support materials. Commercial reagents were analyzed by the newly-developed procedures. Было изучено хроматографическое поведение гидроксиантрахинонов. Хорошее разделение было достигнуто при использовании предложенных новых хроматографических систем: бумажная хроматография смесью уксусной кислоты и воды на простой бумаге или бумаге импрегнированной оливковым мас­ лом, тонкослойная хроматография на целлюлозе импрегнированной диметилфор- мамидом и на силикагеле без или с импрегнацией щавелевой или борной кислотами. Anthraquinones constitute an important class of organic substances. They are produced industrially as dyes [1] and occur also in natural products [2]. The fact that some hydroxyanthraquinones react with metal cations to give colour chelates has been utilized in analytical chemistry [3]. Anthraquinone and its derivatives can be determined spectrophotometrically [4—6] and by polarography [4]. The determination of anthraquinones is frequently preceded by a chromatographic separation the purpose of which is to prepare a chemically pure substance. For chromatographic separation of anthraquinone derivatives common paper [7—9] and paper impregnated with dimethylformamide or 1-bromonaphthalene has been used [10, 11]. Dyes derived from anthraquinone have also been chromatographed on thin layers of cellulose containing 10% of acetylcellulose [12]. Thin-layer chromatography on silica gel has been applied in the separation of dihydroxyanthraquinones [13], di- and trihydroxycarbox- ylic acids of anthraquinones [14] and anthraquinones occurring in nature [15].
    [Show full text]
  • United States Patent (19) 11 Patent Number: 4,746,461 Zielske (45) Date of Patent: May 24, 1988
    United States Patent (19) 11 Patent Number: 4,746,461 Zielske (45) Date of Patent: May 24, 1988 54 METHOD FOR PREPARING 4,041,051 8/1977 Yamado et al. ..................... 260/371 1,4-DIAMINOANTHRAQUINONES AND 4,661,293 4/1987 Zielske ................................ 260/377 INTERMEDIATES THEREOF FOREIGN PATENT DOCUMENTS 75 Inventor: Alfred G. Zielske, Pleasanton, Calif. 2014178 8/1979 United Kingdom................ 260/377 2019870 1 1/1979 United Kingdom ..... ... 260/377 73 Assignee: The Clorox Company, Oakland, Calif. 2100307A 5/1980 United Kingdom ................ 260/377 (21) Appl. No.: 945,906 OTHER PUBLICATIONS 22 Filed: Dec. 23, 1986 Morrison & Boyd, Organic Chemistry, 3rd ed., 1973, pp. 458, 456,527, 528. s Related U.S. Application Data Chemical Abstract, vol. 88, #10498g&h, Schultz et al., 60 Division of Ser. No. 868,884, May 23, 1986, Pat. No. 1978, "Synthesis of Meso-Substituted Hydroxyantha 4,661,293, which is a continuation of Ser. No. 556,835, rones with Laxative Activity Parts I & II' Arch. Dec. 1, 1983, abandoned. Pharm, vol. 310, No. 10, pp. 769-780, 1977. 51 Int. Cl." ...................... C11D 15/02; C11D 13/00 Primary Examiner-Glennon H. Hollrah 52 U.S. C. .................................... 260/370; 260/371; Assistant Examiner-Raymond Covington 260/374 Attorney, Agent, or Firm-Majestic, Gallagher, Parsons 58 Field of Search ............... 260/370, 371, 377, 378, & Siebert 260/374 (57) ABSTRACT (56) References Cited Aminoanthraquinones are generally useful as dyes and U.S. PATENT DOCUMENTS coloring agents. But known methods of synthesizing 2,174,751 10/1939 Koerberle ........................... 260/367 unsymmetrically substituted 1,4-diaminoanthraquinones 2,183,652 12/1939 Lord ............
    [Show full text]
  • Anthraquinones Mireille Fouillaud, Yanis Caro, Mekala Venkatachalam, Isabelle Grondin, Laurent Dufossé
    Anthraquinones Mireille Fouillaud, Yanis Caro, Mekala Venkatachalam, Isabelle Grondin, Laurent Dufossé To cite this version: Mireille Fouillaud, Yanis Caro, Mekala Venkatachalam, Isabelle Grondin, Laurent Dufossé. An- thraquinones. Leo M. L. Nollet; Janet Alejandra Gutiérrez-Uribe. Phenolic Compounds in Food Characterization and Analysis , CRC Press, pp.130-170, 2018, 978-1-4987-2296-4. hal-01657104 HAL Id: hal-01657104 https://hal.univ-reunion.fr/hal-01657104 Submitted on 6 Dec 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Anthraquinones Mireille Fouillaud, Yanis Caro, Mekala Venkatachalam, Isabelle Grondin, and Laurent Dufossé CONTENTS 9.1 Introduction 9.2 Anthraquinones’ Main Structures 9.2.1 Emodin- and Alizarin-Type Pigments 9.3 Anthraquinones Naturally Occurring in Foods 9.3.1 Anthraquinones in Edible Plants 9.3.1.1 Rheum sp. (Polygonaceae) 9.3.1.2 Aloe spp. (Liliaceae or Xanthorrhoeaceae) 9.3.1.3 Morinda sp. (Rubiaceae) 9.3.1.4 Cassia sp. (Fabaceae) 9.3.1.5 Other Edible Vegetables 9.3.2 Microbial Consortia Producing Anthraquinones,
    [Show full text]
  • Fundamentals of Natural Dyes and Its Application on Textile Substrates Virendra Kumar Gupta
    Chapter Fundamentals of Natural Dyes and Its Application on Textile Substrates Virendra Kumar Gupta Abstract The meticulous environmental standards in textiles and garments imposed by countries cautious about nature and health protection are reviving interest in the application of natural dyes in dyeing of textile materials. The toxic and allergic reactions of synthetic dyes are compelling the people to think about natural dyes. Natural dyes are renewable source of colouring materials. Besides textiles it has application in colouration of foods, medicine and in handicraft items. Though natural dyes are ecofriendly, protective to skin and pleasing colour to eyes, they are having very poor bonding with textile fibre materials, which necessitate mordant- ing with metallic mordants, some of which are not eco friendly, for fixation of natural dyes on textile fibres. So the supremacy of natural dyes is somewhat sub- dued. This necessitates newer research on application of natural dyes on different natural fibres for completely eco friendly textiles. The fundamentals of natural dyes chemistry and some of the important research work are therefore discussed in this review article. Keywords: colour fastness, dyeing, extraction of natural dyes, natural dyes 1. Introduction After the advent of mauveine by Henry Perkin in 1856 and subsequent commer- cialization of synthetic dyes had replaced natural dyes, and since then consumption and application of natural dyes for textiles got reduced substantially. In present scenario environmental consciousness of people about natural products, renewable nature of materials, less environmental damage and sustainability of the natural products has further revived the use of natural dyes in dyeing of textile materials.
    [Show full text]
  • Helicopter Transmission Oil Discolouration
    UNCLASSIFIED Helicopter Transmission Oil Discolouration Andrew Becker and Paul Rawson Air Vehicles Division Defence Science and Technology Organisation DSTO-TR-2672 ABSTRACT An increase in the incidence of abnormal discolouration of oil in ADF helicopter tail rotor transmissions has been observed and reported over the last eight years. Aircraft maintainers have initially attributed the discolouration to a range of contamination modes including incorrect fluid addition, hydraulic fluid contamination and degraded fluid. A program of work was conducted at DSTO to identify and characterise the cause of the abnormal discolouration. This report details the identification of a coloured metal quinizarate salt which forms in the aircraft transmissions under normal operating conditions and describes the mechanism of formation and some characteristics of the quinizarate salt to assist in developing maintenance programs to manage the coloured salt when observed in service conditions. RELEASE LIMITATION Approved for public release UNCLASSIFIED UNCLASSIFIED Published by Air Vehicles Division DSTO Defence Science and Technology Organisation 506 Lorimer St Fishermans Bend, Victoria 3207 Australia Telephone: (03) 9626 7000 Fax: (03) 9626 7999 © Commonwealth of Australia 2012 AR-015-243 February 2012 APPROVED FOR PUBLIC RELEASE UNCLASSIFIED UNCLASSIFIED Helicopter Transmission Oil Discolouration Executive Summary Effective lubrication of modern military aircraft transmissions requires the use of highly specified synthetic polyol ester lubricants. Significant effort can be expended in ensuring serviceability of these oils through a range of oil condition monitoring programs. The current oil used in many ADF helicopter transmissions meets the MIL-PRF-23699 specification and a number of specific brands of oil meeting this specification are in routine service within the ADF.
    [Show full text]
  • PROVISIONAL PEER REVIEWED TOXICITY VALUES for ALIZARIN RED COMPOUNDS (VARIOUS CASRNS) Derivation of Subchronic and Chronic Oral Rfds
    EPA/690/R-04/001F l Final 12-20-2004 Provisional Peer Reviewed Toxicity Values for Alizarin Red Compounds (Various CASRNs) Derivation of Subchronic and Chronic Oral RfDs Superfund Health Risk Technical Support Center National Center for Environmental Assessment Office of Research and Development U.S. Environmental Protection Agency Cincinnati, OH 45268 Acronyms and Abbreviations bw body weight cc cubic centimeters CD Caesarean Delivered CERCLA Comprehensive Environmental Response, Compensation and Liability Act of 1980 CNS central nervous system cu.m cubic meter DWEL Drinking Water Equivalent Level FEL frank-effect level FIFRA Federal Insecticide, Fungicide, and Rodenticide Act g grams GI gastrointestinal HEC human equivalent concentration Hgb hemoglobin i.m. intramuscular i.p. intraperitoneal i.v. intravenous IRIS Integrated Risk Information System IUR inhalation unit risk kg kilogram L liter LEL lowest-effect level LOAEL lowest-observed-adverse-effect level LOAEL(ADJ) LOAEL adjusted to continuous exposure duration LOAEL(HEC) LOAEL adjusted for dosimetric differences across species to a human m meter MCL maximum contaminant level MCLG maximum contaminant level goal MF modifying factor mg milligram mg/kg milligrams per kilogram mg/L milligrams per liter MRL minimal risk level i MTD maximum tolerated dose MTL median threshold limit NAAQS National Ambient Air Quality Standards NOAEL no-observed-adverse-effect level NOAEL(ADJ) NOAEL adjusted to continuous exposure duration NOAEL(HEC) NOAEL adjusted for dosimetric differences across species
    [Show full text]
  • Isolation and Synthesis of Anthraquinones and Related Compounds of Rubia Cordifolia
    J. Serb. Chem. Soc. 70 (7) 937–942 (2005) UDC 633.863:547.263:542.913 JSCS – 3329 Original scientific paper Isolation and synthesis of anthraquinones and related compounds of Rubia cordifolia RAM SINGHa,b* and GEETANJALIb aCentre for Environmental Management of Degraded Ecosystems, School of Environmental Studies, University of Delhi, Delhi – 110 007 and bDepartment of Chemistry, University of Delhi, Delhi – 110 007, India (e-mail: [email protected]) (Received 17 August 2004) Abstract: Anthraquinones and their glycosides, along with other compounds, have been isolated and characterized from the acetone:water (1:1) percolation of dried roots of Rubia cordifolia. Selected anthraquinones were synthesized using montmo- rillonite clays under solventless condition in 75 to 85 % yield. Keywords: Anthraquinones, Rubia cordifolia, montmorillonite clays. INTRODUCTION The family Rubiaceae comprises about 450 genera and 6500 species and in- cludes trees, shrubs and infrequently herbs. Rubia cordifolia is a perennial, herba- ceous climbing plant, with very long roots, cylindrical, flexuous, with a thin red bark.1 Stems often have a long, rough, grooved, woody base. Plants belonging to this family are known to contain substantial amounts of anthraquinones, especially in the roots.2,3 The traditional therapeutic use of the plant has been for skin disorders and for anticancer activity.3–5 Furthermore, the anthraquinones of the Rubiaceae family exhibit some interesting in vivo biological activities, such as antimicrobial,6 antifungal,7 hypotensive,8 analgesic,8 antimalarial,5,9 antioxidant,10 antileukemic and mutagenic functions.11,12 Apart from its medicinal value, this plant has also been used as natural food colourants and as natural hair dyes.13 The interest in the isolation of natural dyes and colouring matters is increasing due to their applica- tions in food, drugs and other human consumptions.
    [Show full text]
  • Suppression Effect of Purpurin Derivatives on Nitric Oxide Synthase
    J. Korean Soc. Appl. Biol. Chem. 54(2), 302-307 (2011) Short Communication Suppression Effect of Purpurin Derivatives on Nitric Oxide Synthase Hoi-Seon Lee* Department of Bioenvironmental Chemistry and Institute of Agricultural Science & Technology, College of Agriculture & Life Science, Chonbuk National University, Jeonju 561-756, Republic of Korea Received September 1, 2010; Accepted September 9, 2010 The inhibitory effects of Rubia tinctorum root-derived materials against nitric oxide (NO) production were assessed by evaluation of NO production and inducible NO synthase (iNOS) expression, and compared to those of trihydroxyanthraquinone derivatives. The inhibitory effect of 1,2,4-trihydroxyanthraquinone (purpurin) from R. tinctorum roots against NO production was 60.7 and 38.5% at 2.5 and 1.25 μg/mL, respectively. Inhibitory effect of 1,2,7-trihydroxy- anthraquinone was 52.5% at 2.5 μg/mL. Suppression effects of 1,2,4-trihydroxyanthraquinone on iNOS expression were confirmed by western blot analysis. Key words: functional foods, inducible nitric oxide synthase, NO production, Rubia tinctorum, 1,2,4-trihydroxyanthraquinone Medicinal plants may prove to be an alternative to the murine peritoneal macrophages following stimulation inducible nitric oxide synthase (iNOS) inhibitors presently with LPS. in use, as the plants constitute a rich source of active Acrylamide, ε-amino-n-caproic acid, bovine serum chemicals [Lee et al., 2000; 2002; Lee, 2011]. Because albumin, brilliant blue G-250, 1,3,8-trihydroxyanthraquinone, these plant-derived compounds are largely free from 6-methyl-1,3,8-trihydroxyanthraquinone, ethylene diamine adverse effects, studies may facilitate the development of acid, leupeptin, lipopolysaccharide, N,N'-methylene-bis- safer iNOS inhibitors.
    [Show full text]
  • New Insights in Alzheimer's Disease
    pharmaceuticals Review Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer’s Disease Marta Campora † , Valeria Francesconi †, Silvia Schenone, Bruno Tasso and Michele Tonelli * Dipartimento di Farmacia, Università degli Studi di Genova, Viale Benedetto XV, 3, 16132 Genova, Italy; [email protected] (M.C.); [email protected] (V.F.); [email protected] (S.S.); [email protected] (B.T.) * Correspondence: [email protected] † These authors equally contributed to the study and both should be considered as first author. Abstract: Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline leading to dementia and death. AD imposes neuronal death by the intricate interplay of different neurochemical factors, which continue to inspire the medicinal chemist as molecular targets for the development of new agents for the treatment of AD with diverse mechanisms of action, but also depict a more complex AD scenario. Within the wide variety of reported molecules, this review summarizes and offers a global overview of recent advancements on naphthoquinone (NQ) and anthraquinone (AQ) derivatives whose more relevant chemical features and structure-activity relationship studies will be discussed with a view to providing the perspective for the design of viable drugs for the treatment of AD. In particular, cholinesterases (ChEs), β-amyloid (Aβ) and tau proteins have been identified as key targets of these classes of compounds, where the NQ or AQ scaffold may contribute to the biological effect against AD as main unit or significant substructure. The multitarget directed ligand (MTDL) strategy will be described, as a chance for these molecules to exhibit significant potential on the road to therapeutics for AD.
    [Show full text]
  • Influence of Structural Characteristics of Substituents on the Antioxidant
    Computational and Theoretical Chemistry xxx (2015) xxx–xxx Contents lists available at ScienceDirect Computational and Theoretical Chemistry journal homepage: www.elsevier.com/locate/comptc Influence of structural characteristics of substituents on the antioxidant activity of some anthraquinone derivatives ⇑ Zoran Markovic´ a, , Svetlana Jeremic´ a, Jasmina Dimitric´ Markovic´ b, Marijana Stanojevic´ Pirkovic´ c, Dragan Amic´ d a Department of Chemical-Technological Sciences, State University of Novi Pazar, Vuka Karadzˇic´a bb, 36300 Novi Pazar, Serbia b Faculty of Physical Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia c Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovic´a 69, 34000 Kragujevac, Serbia d Faculty of Agriculture, The Josip Juraj Strossmayer University, Kralja Petra Svacˇic´a 1d, HR-31000 Osijek, Croatia article info abstract Article history: The antioxidant activity of chrysophanol (CH), emodin (EM), aloe-emodin (AE), and 1,3,8- Received 31 August 2015 trihydroxyanthraquinone (THA) was examined in water and pentyl ethanoate by using the M052X/ Received in revised form 4 October 2015 6-311++G(d,p) level of theory. It was shown that hydrogen bonds are of significant importance for the Accepted 4 October 2015 stability of the radical and anionic species obtained in the HAT and SPLET mechanisms. Consequently, Available online xxxx all radicals and anions formed with retention of O9ÁÁÁH1–O1 and O9ÁÁÁH8–O8 hydrogen bonds are more stable than those where the hydrogen bonds are disturbed. The exceptions are the radical and anion of Keywords: AE, the unpaired electron or negative charge is poorly delocalized. Anthraquinones The high IP values for all investigated compounds undoubtedly discredit the SET-PT mechanism.
    [Show full text]
  • Anthraquinones As Inhibitors of Sulfide Production from Sulfate-Reducing Bacteria
    Europaisches Patentamt 19 European Patent Office Office europeen des brevets © Publication number: 0 525 073 B1 12 EUROPEAN PATENT SPECIFICATION © Date of publication of patent specification © int. ci.5: A01N 35/06, C12Q 1/04, 25.05.94 Bulletin 94/21 C12Q 1/18 © Application number : 91908405.3 © Date of filing : 19.03.91 © International application number : PCT/US91/01734 @ International publication number : WO 91/15954 31.10.91 Gazette 91/25 @ ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. © Priority: 18.04.90 US 510763 © Proprietor : E.I. DU PONT DE NEMOURS AND 07.02.91 US 652406 COMPANY 1007 Market Street Wilmington Delaware 19898 (US) @ Date of publication of application 03.02.93 Bulletin 93/05 © Inventor : ANDERSON, Albert Gordon 2410 St. Francis Street (45) Publication of the grant of the patent : Wilmington, DE 19808 (US) 25.05.94 Bulletin 94/21 Inventor : COOLING, Frederick Beiswanger, III 521 Cabot Drive @ Designated Contracting States : Hockessin, DE 19707-0731 (US) AT BE CH DE ES FR GB GR IT LI NL Inventor : ODOM, James Martin 28 Hilltop Road Avondale, PA 19311 (US) © References cited : Inventor : WEIMER, Paul James EP-A- 0 094 721 14 Oxwood Circle CH-A- 505 900 Madison, Wl 53717 (US) CH-A- 614 466 GB-A- 2 155 453 US-A- 4 532 117 © Representative : Jones, Alan John et al CHEMICAL ABSTRACTS, vol. 43, no. 7, 10 April CARPMAELS & RANSFORD 1949, Columbus, Ohio, US; M. ANCHEL: 43 Bloomsbury Square "Identification of the antibiotic substance London, WC1A 2RA (GB) from cassia reticulata as 4,5-dihydroxyanthra- CO quinone-2-carboxylic acid", abstract no.
    [Show full text]
  • Identification of Hydroxyanthraquinones As Novel Inhibitors of Hepatitis C Virus NS3 Helicase
    Int. J. Mol. Sci. 2015, 16, 18439-18453; doi:10.3390/ijms160818439 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase Atsushi Furuta 1,2, Masayoshi Tsubuki 3, Miduki Endoh 3, Tatsuki Miyamoto 1,2, Junichi Tanaka 4, Kazi Abdus Salam 5,†, Nobuyoshi Akimitsu 5, Hidenori Tani 6, Atsuya Yamashita 7, Kohji Moriishi 7, Masamichi Nakakoshi 8, Yuji Sekiguchi 2, Satoshi Tsuneda 1,* and Naohiro Noda 1,2,* 1 Department of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan; E-Mails: [email protected] (A.F.); [email protected] (T.M.) 2 Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan; E-Mail: [email protected] 3 Institute of Medical Chemistry, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan; E-Mails: [email protected] (M.T.); [email protected] (M.E.) 4 Department of Chemistry, Biology and Marine Science, University of the Ryukyus, Nishihara, Okinawa 903-0213, Japan; E-Mail: [email protected] 5 Radioisotope Center, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan; E-Mails: [email protected] (K.A.S.); [email protected] (N.A.) 6 Environmental Measurement Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa,
    [Show full text]